Namocatcat, Marites G.
HRN: 09-47-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/12/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/12/2025
02/19/2025
IV
600mg
Q6
DM Foot
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes